Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Enanta Pharmaceuticals Inc. buy Westpark Capital

Start price
€7.60
02.09.25 / 50%
Target price
€20.51
02.09.26
Performance (%)
60.53%
Price
€12.20
29.09.25
Summary
This prediction is currently active. The BUY prediction by Westpark_Capital for Enanta Pharmaceuticals Inc. has seen massive gains of 60.53%. This prediction currently runs until 02.09.26. The prediction end date can be changed by Westpark_Capital at any time. Westpark_Capital has 50% into this prediction
Performance without dividends (%)
Name 1w
Enanta Pharmaceuticals Inc. 0.781%
iShares Core DAX® 0.696%
iShares Nasdaq 100 0.033%
iShares Nikkei 225® -0.420%
iShares S&P 500 0.153%

Comments by Westpark_Capital for this prediction

In the thread Enanta Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 60.53%
Target price 20.508
Change
Ends at 02.09.26

Enanta Pharmaceuticals (NASDAQ:ENTA) is now covered by analysts at Westpark Capital. They set a "buy" rating and a $24.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat

Stopped prediction by Westpark_Capital for Enanta Pharmaceuticals Inc.

buy
Enanta Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.60
15:01
€23.89
30.09.26
0.00%
29.09.25